SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

From textile recycling to autonomous vessels: The vision behind the Dream Team startups

ELNET: German business leaders “are looking with admiration and respect towards the Startup Nation”

Übermorgen Ventures: “The fundamentals of climate tech haven't changed”

Unit 8200 veterans raise $22 million Series A for real-time impersonation defense

Buzz

Most popular

Daily

Weekly

1

Inside the mind of a Nobel physicist: John Martinis on the future of quantum computing

2

Check Point raises $1.75 billion, potentially eyeing AI expansion

3

Hapag-Lloyd eyes ZIM acquisition, workers push back

4

Sequoia’s Shaun Maguire says Israel risks losing “a war it can’t see”

5

Nice puts Actimize up for sale at a $1.5-2 billion price tag

PhaseV

4 stories about PhaseV

Promising HealthTech

WATCH: CTech's most promising healthtech startups

Here's everything you need to know about Sensi.ai, Briya Labs, PhaseV, Zorro, and DeepCure

כנס ניו יורק - ד"ר רביב פרילוק מנכ"ל PhaseV

PhaseV raises $50 million Series A to rethink how drugs get to market

With over 30 global customers, the AI startup targets inefficiencies in clinical trials.

CTech NY Conference Dr Raviv Pryluk

Here’s how PhaseV uses AI to optimize clinical trials to speed clinical development

27.03.25|James Spiro

CEO and Co-Founder Dr. Raviv Pryluk spoke to CTech after being named as one of the Top 10 Israeli startups to watch out for in 2025 at Calcalist’s Mind The Tech conference in New York.

Raviv Pryluk PhaseV

PhaseV raises $15 million to optimize clinical trials with causal machine learning

The Israeli startup detects hidden signals in clinical data and extracts actionable insights for planning the next steps